Genetic testing for pheochromocytoma and paraganglioma: SDHx carriers' experiences

被引:2
|
作者
Martins, Raquel Gomes [1 ,2 ,3 ]
Carvalho, Irene Palmares [2 ,4 ]
机构
[1] Portuguese Oncol Inst Coimbra, Dept Endocrinol, Porto, Portugal
[2] Univ Porto, Sch Med, Med Psychol Unit, Dept Clin Neurosci & Mental Hlth, Porto, Portugal
[3] Portuguese Oncol Inst Oporto, Res Ctr, Porto, Portugal
[4] Univ Porto, Sch Med, CINTESIS, Porto, Portugal
关键词
carrier testing; genetic testing; hereditary cancer; lived experience; paraganglioma; pheochromocytoma;
D O I
10.1002/jgc4.1390
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Pheochromocytoma and paraganglioma are frequently hereditary tumors commonly associated with succinate dehydrogenase (SDHx) pathogenic variants (PV). Genetic testing is recommended to relatives of patients carrying SDHx PV. This study aims to explore the experiences associated with genetic testing for this hereditary condition. Semi-structured interviews with 38 SDHx PV (tumor-affected and non-affected) carriers were transcribed and content-analyzed. Four ways of living with this genetic alteration emerged from the interviews: 'living as if not knowing', 'preventing others from going through this', 'feeling privileged', and 'still suffering'. Within each, negative, neutral, and positive reactions to the actual test result emerged initially, in addition to blame and guilt. Recognition of the importance of the genetic test and of the follow-up occurred in all four, but views on fecundity were divided between having and not having children. Consideration for the four different meanings of carrying an SDHx PV can improve participants' experiences and clinical practice.
引用
收藏
页码:872 / 884
页数:13
相关论文
共 50 条
  • [31] Genetic Characteristics of Incidental Pheochromocytoma and Paraganglioma
    Zhang, Jing
    Li, Minghao
    Pang, Yingxian
    Wang, Cikui
    Wu, Jingjing
    Cheng, Ziyun
    Li, Xiaomu
    Lu, Zhiqiang
    Liu, Yujun
    Guo, Jianming
    Chen, Xiang
    He, Yao
    Guan, Xiao
    Xu, Xiaowen
    Wang, Yong
    Liu, Jiahao
    Guo, Wei
    Hou, Yingyong
    Liu, Longfei
    Jiang, Jingjing
    Gao, Xin
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (05): : E1835 - E1842
  • [32] Optimal Screening for Hereditary Head and Neck Paraganglioma in Asymptomatic SDHx Variant Carriers in the Netherlands
    Heesters, Anouk Frederique
    Tops, Carli
    Potjer, Thomas
    Corssmit, Eleonora P. M.
    Bayley, Jean-Pierre
    Hensen, Erik
    Jansen, Jeroen
    JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE, 2025, 86 (01) : 1 - 5
  • [33] The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers
    Rijken, J. A.
    Niemeijer, N. D.
    Jonker, M. A.
    Eijkelenkamp, K.
    Jansen, J. C.
    van Berkel, A.
    Timmers, H. J. L. M.
    Kunst, H. P. M.
    Bisschop, P. H. L. T.
    Kerstens, M. N.
    Dreijerink, K. M. A.
    van Dooren, M. F.
    van der Horst-Schrivers, A. N. A.
    Hes, F. J.
    Leemans, C. R.
    Corssmit, E. P. M.
    Hensen, E. F.
    CLINICAL GENETICS, 2018, 93 (01) : 60 - 66
  • [34] Pheochromocytoma and paraganglioma: molecular testing and personalized medicine
    Burnichon, Nelly
    Buffet, Alexandre
    Gimenez-Roqueplo, Anne-Paule
    CURRENT OPINION IN ONCOLOGY, 2016, 28 (01) : 5 - 10
  • [35] A Clinical Efficacy of PRRT in Patients with Advanced, Nonresectable, Paraganglioma-Pheochromocytoma, Related to SDHx Gene Mutation
    Kolasinska-Cwikla, Agnieszka
    Peczkowska, Mariola
    Cwikla, Jaroslaw B.
    Michalowska, Ilona
    Palucki, Jakub M.
    Bodei, Lisa
    Lewczuk-Myslicka, Anna
    Januszewicz, Andrzej
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (07):
  • [36] Inherited Mutations in Pheochromocytoma and Paraganglioma: Why All Patients Should Be Offered Genetic Testing
    Fishbein, Lauren
    Merrill, Shana
    Fraker, Douglas L.
    Cohen, Debbie L.
    Nathanson, Katherine L.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (05) : 1444 - 1450
  • [37] Inherited Mutations in Pheochromocytoma and Paraganglioma: Why All Patients Should Be Offered Genetic Testing
    Lauren Fishbein
    Shana Merrill
    Douglas L. Fraker
    Debbie L. Cohen
    Katherine L. Nathanson
    Annals of Surgical Oncology, 2013, 20 : 1444 - 1450
  • [38] Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or Paraganglioma
    Arenas, Minerva A. Romero
    Rich, Thereasa A.
    Hyde, Samuel M.
    Busaidy, Naifa L.
    Cote, Gilbert J.
    Hu, Mimi I.
    Gagel, Robert F.
    Gidley, Paul W.
    Jimenez, Camilo
    Kupferman, Michael E.
    Peterson, Susan K.
    Sherman, Steven I.
    Ying, Anita
    Bassett, Roland L., Jr.
    Waguespack, Steven G.
    Perrier, Nancy D.
    Grubbs, Elizabeth G.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (05) : 1395 - 1402
  • [39] Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or Paraganglioma
    Minerva A. Romero Arenas
    Thereasa A. Rich
    Samuel M. Hyde
    Naifa L. Busaidy
    Gilbert J. Cote
    Mimi I. Hu
    Robert F. Gagel
    Paul W. Gidley
    Camilo Jimenez
    Michael E. Kupferman
    Susan K. Peterson
    Steven I. Sherman
    Anita Ying
    Roland L. Bassett
    Steven G. Waguespack
    Nancy D. Perrier
    Elizabeth G. Grubbs
    Annals of Surgical Oncology, 2018, 25 : 1395 - 1402
  • [40] Pheochromocytoma, paraganglioma and genetic syndromes: a historical perspective
    Else, Tobias
    ENDOCRINE-RELATED CANCER, 2015, 22 (04) : T147 - T159